Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oncology Institute (TOI) EPS (Basic) (2020 - 2025)

Oncology Institute (TOI) has disclosed EPS (Basic) for 6 consecutive years, with -$0.14 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Basic) rose 22.22% year-over-year to -$0.14, compared with a TTM value of -$0.63 through Sep 2025, up 19.23%, and an annual FY2024 reading of -$0.71, up 22.83% over the prior year.
  • EPS (Basic) was -$0.14 for Q3 2025 at Oncology Institute, roughly flat from -$0.14 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.85 in Q2 2021 and bottomed at -$0.33 in Q1 2023.
  • Average EPS (Basic) over 5 years is -$0.08, with a median of -$0.14 recorded in 2025.
  • The sharpest move saw EPS (Basic) skyrocketed 1200.0% in 2022, then crashed 533.33% in 2023.
  • Year by year, EPS (Basic) stood at -$0.15 in 2021, then increased by 20.0% to -$0.12 in 2022, then crashed by 75.0% to -$0.21 in 2023, then soared by 33.33% to -$0.14 in 2024, then decreased by 0.0% to -$0.14 in 2025.
  • Business Quant data shows EPS (Basic) for TOI at -$0.14 in Q3 2025, -$0.14 in Q2 2025, and -$0.21 in Q1 2025.